NPHS1 and Alport syndrome: Additionally, if the mutation disrupts the protein severely enough, a transplant will expose the recipient to de novo antigens from the donor kidney, such as has been reported with NPHS1 (congenital nephrotic syndrome) and COL4A5 (Alport syndrome)39–43.